Sopharma AD
Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.
SFA | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG11SOSOBT18
- LEI:
- 097900BGGW0000048796
- Country:
- Bulgaria
- Address:
- ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София
- Website:
- https://www.sopharmagroup.com/
- Sector:
- Manufacturing
Description
Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-22 10:49 |
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (E…
|
English | 162.4 KB | ||
| 2024-02-22 10:45 |
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (E…
|
English | 160.5 KB | ||
| 2024-02-20 15:19 |
zal01_Donev_Sopharma_temp_issue_EN_19022024.pdf
|
English | 142.3 KB | ||
| 2024-02-20 15:16 |
zal01_Donev_Sopharma_exercise_EN_19022024.pdf
|
English | 140.6 KB | ||
| 2024-02-20 11:06 |
zal01_Donev_Sopharma_EN_19022024.pdf
|
English | 142.7 KB | ||
| 2024-02-20 11:02 |
zal01_Donev_Sopharma_EN_19022024.pdf
|
English | 140.9 KB | ||
| 2024-02-19 13:05 |
Notification for Sales revenues for January 2024
|
English | 83.6 KB | ||
| 2024-01-31 14:08 |
Technical error in the Notification under Art. 89t of the Law on Public Offerin…
|
English | 62.4 KB | ||
| 2024-01-30 13:34 |
Individual financial report according to IFRS as of 31 December 2023
|
Polish | 3.7 MB | ||
| 2024-01-26 14:18 |
Notification according to Art. 89t of the LPOS concerning an increase of the ca…
|
English | 80.2 KB | ||
| 2024-01-26 13:45 |
Sopharma AD-Sofia presented inutes of the General Meeting of Warrant Holders he…
|
Polish | 441.5 KB | ||
| 2024-01-22 13:05 |
Sales revenues for December 2023
|
English | 85.2 KB | ||
| 2024-01-19 13:32 |
Presentation of materials and Invitation for General Meeting of Warrant holders…
|
Polish | 789.7 KB | ||
| 2024-01-15 16:13 |
Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD
|
English | 59.3 KB | ||
| 2024-01-10 13:03 |
"Sopharma" AD starts the payment of the dividend for the 6 months of 2023 on Ja…
|
English | 63.1 KB |
Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sopharma AD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sopharma AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
